Page 2 - Saliva Glucose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Saliva glucose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Saliva Glucose Today - Breaking & Trending Today

GBS Inc. Announces Application for FDA Breakthrough Device

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for. ....

United States , Spiro Sakiris , Asia Pacific , Tim Mccarthy , Steven Boyages , Biosensx North America Inc , Lifesci Advisors , Company Contact , Drug Administration , Purpose Of The Program , Life Science Biosensor Diagnostics Pty Ltd , Gbs Inc , Exchange Commission , Breakthrough Devices Program , Newcastle University , Devices Breakthrough Program , Securities Exchange , Rapid Saliva Glucose Test , Breakthrough Device , Breakthrough Program , Saliva Glucose , Biosensor Platform , North America , North American , Rapid Saliva Glucose Tests , Devices Program ,

GBS Inc. Reports First Quarter 2021 Financial Results and Recent Business Highlights

GBS Inc. Reports First Quarter 2021 Financial Results and Recent Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Harry Simeonidis , George Syrmalis , Harvard Longwood , Jeremy Feffer , James Gorman , Johns Hopkins University , Bloomberg School Of Public Health , Company Contact , John Hopkins University , Harvard University , Wyss Institute , Iq Group Global , Wyss Institute For Biologically Inspired Engineering , Lifesci Advisors , Gbs Inc , Exchange Commission , Company Biosensor , Securities Exchange , University Of Newcastle , Precision Medicine Architects , Emergency Use Submission , Biosensor Test , Second Half , Cash Equivalents , Marketable Securities ,

IQX Limited (NSX:IQX) Progress of Clinical Programs - ABN Newswire (@ABN_Newswire)

IQX Limited (NSX:IQX) Progress of Clinical Programs

Progress of Clinical ProgramsSydney, April 29, 2021 AEST (ABN Newswire) - iQX Limited (iQX Ltd) (
NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository. The study follows a partnership with the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Institute), through Life Science Biosensor Diagnostics Pty Ltd subsidiary, GBS Inc. (
Nasdaq:GBS), a Delaware corporation, to develop a novel diagnostic SARS-CoV-2 test. ....

New York , United States , New South Wales , United Kingdom , Charles River , Jonathan Sessler , George Syrmalis , Harvard Longwood , Harvard University Wyss Institute , Johns Hopkins University , Bloomberg School Of Public Health , Holdings Inc , Biosensx North America Inc , Md Anderson Cancer Center , Ut Dell Medical School , Life Science Biosensor Diagnostics Pty Ltd , Qx Ltd , Wyss Institute , Oncotex Inc , Iq Group Global , Iq Group Global Ltd , Sterling Pharma Solutions , Biosensx Europe Inc , Most Innovative Companies , University Of Texas At Austin , Research Agreement ,

GBS Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

GBS Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Harry Simeonidis , George Syrmalis , Jeremy Feffer , Gemma Garkut , Harvard University Wyss Institute , Johns Hopkins University , Company Contact , Wyss Institute Cambridge Consultants Ltd , Cambridge Consultants Ltd , John Hopkins University , Newcastle University , Wyss Institute Of Harvard , Iq Group Global , Lifesci Advisors , School Of Public Health , Research Collaboration , Gbs Inc , Exchange Commission , Pipeline Development , Securities Exchange , Public Offering , Executes Partnerships , Hopkins University , Wyss Institute , Cambridge Consultants ,

2 More IPOs Make Their Trading Debuts Today

GBS
opened for trading and both ended up breaking in their debuts.
Shares of Inhibikase (ticker: IKT) rose as much as 18% Wednesday. The stock opened at $10.67, hit a high of $11.80, and closed at $9.90. Because it finished 10 cents below its $10 IPO price, Inhibikase is considered a broken deal.
Late Tuesday, Inhibikase raised $18 million after cutting the size of its deal but pricing significantly above its expected range. The Atlanta company had initially planned to sell 2,272,727 shares at $10 to $12, then cut it to 1.4 million, which was then reduced to the current 1.8 million shares at $10 each.
Inhibikase was scheduled to trade last month, but delayed the deal. ThinkEquity, a division of Fordham Financial Management, is the underwriter on the deal. ....

New York , United States , Luisa Beltran , Milton Werner , Harvard University , Drug Administration , Iq Group Global , Inhibikase Therapeutics , James Securities , Saliva Glucose Biosensor , Saliva Glucose , Life Science Biosensor Diagnostics Pty , Science Biosensor Diagnostics , Life Science Biosensor , Fordham Financial Management , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , லூயிசா பெல்ட்ரான் , மில்டன் வெர்னர் , ஹார்வர்ட் பல்கலைக்கழகம் , க்யூ குழு உலகளாவிய , ஜேம்ஸ் பத்திரங்கள் , ஃபார்டம் நிதி மேலாண்மை ,